Clinical Trial

Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions

Study acronym: OCAPI
Recruiting
View on ClinicalTrials.gov →
Summary
The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-09-23; most recent amendment 2025-12-23.
Status change: Not Yet Recruiting → Recruiting 2025-09-16
Trial Details
NCT Number NCT06612827
Lead Sponsor Centre Francois Baclesse
Conditions Undifferentiated Carcinoma
Enrollment 20 participants
Start Date 2025-03-05
Primary Completion 2028-12-15 (estimated)
Study Completion 2032-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-24